Research programme: retinoic acid inducible gene I protein stimulants - KinetaAlternative Names: Research programme: DDX58 protein stimulants - Kineta; Research programme: RIG-I protein stimulants - Kineta
Latest Information Update: 16 Jul 2016
At a glance
- Originator Kineta
- Class Small molecules; Vaccines
- Mechanism of Action DDX58 protein stimulants; Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Viral infections